Evercore's 15min chart shows KDJ Golden Cross and KDJ Death Cross.
ByAinvest
Monday, Sep 8, 2025 3:01 pm ET2min read
ALNY--
The Golden Cross, which occurred when the K-line crossed above the D-line, signals a potential trend reversal from bearish to bullish. This is a commonly used signal in Asian markets and can often precede a significant price increase. Conversely, the Death Cross, which occurs when the K-line crosses below the D-line, followed by the J-line crossing below the K-line, signals a bearish trend, suggesting that the stock price may continue to decline [1].
These technical signals follow a broader trend of narrowing Bollinger Bands and bearish formations observed in several other stocks, including ASGN and Cushing NextGen [1]. Technical analysis provides valuable insights into potential stock price movements, but it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.
As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
References:
[1] https://www.ainvest.com/news/employers-holdings-kdj-golden-cross-bullish-marubozu-15min-chart-2508-83/
ASGN--
BAC--
BCS--
BINI--
According to the 15-minute chart analysis conducted by Evercore, a notable technical indicator event has occurred. Specifically, at 14:45 on September 8, 2025, the KDJ (Kappa-Delta-Joint) indicator has triggered both the Golden Cross and Death Cross signals. This suggests that the momentum of the stock price is shifting in a bullish direction, potentially leading to further upward movement, whereas the momentum is shifting in a bearish direction, potentially leading to further downward movement.
According to the 15-minute chart analysis conducted by Evercore, a notable technical indicator event has occurred. Specifically, at 14:45 on September 8, 2025, the KDJ (Kappa-Delta-Joint) indicator has triggered both the Golden Cross and Death Cross signals. This suggests that the momentum of the stock price is shifting in a bullish direction, potentially leading to further upward movement, whereas the momentum is shifting in a bearish direction, potentially leading to further downward movement.The Golden Cross, which occurred when the K-line crossed above the D-line, signals a potential trend reversal from bearish to bullish. This is a commonly used signal in Asian markets and can often precede a significant price increase. Conversely, the Death Cross, which occurs when the K-line crosses below the D-line, followed by the J-line crossing below the K-line, signals a bearish trend, suggesting that the stock price may continue to decline [1].
These technical signals follow a broader trend of narrowing Bollinger Bands and bearish formations observed in several other stocks, including ASGN and Cushing NextGen [1]. Technical analysis provides valuable insights into potential stock price movements, but it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.
As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
References:
[1] https://www.ainvest.com/news/employers-holdings-kdj-golden-cross-bullish-marubozu-15min-chart-2508-83/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet